Figure 5.
Comparison of CRc between treatment groups. A graphical depiction of the incidence of CRc in patients with ND FLT3mut+ AML ineligible for IIC who received GIL + AZA and AZA is shown.

Comparison of CRc between treatment groups. A graphical depiction of the incidence of CRc in patients with ND FLT3mut+ AML ineligible for IIC who received GIL + AZA and AZA is shown.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal